Urine test boosts HIV pill adherence in young men at risk
NCT ID NCT05353283
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 21 times
Summary
This study tested a new way to help young men who have sex with men (ages 18-30) take their daily HIV prevention pills (PrEP) more consistently. Researchers used a simple urine test to check if the pills were being taken, then gave personalized counseling based on the results. The goal was to make the counseling more effective and ultimately prevent HIV infections in this high-risk group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RISK REDUCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Francisco/San Francisco General Hospital
San Francisco, California, 94110, United States
Conditions
Explore the condition pages connected to this study.